Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion.

People who sign up can help researchers assess whether environmental factors may be the culprits behind the region’s higher cancer burden.

Kim and colleagues will study whether this protein hinders the ability of the immune system to fight MDS and whether it can be blocked to treat MDS.

Founded by Marci Houff, the event supports ovarian cancer research at Vanderbilt-Ingram Cancer Center and patient support initiatives.

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study. The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.